Pharmaceutical companies (Leem)
Mission
Support
Type of actor
Digital Industry Federation
Fields of intervention
Health
Intervention zone
National
What is Leem?
Leem is the trade organization representing pharmaceutical companies operating in France. In December 2024, Leem had 280 member companies and employed more than 106,000 people.
Missions
- Represent and defend the interests of its members;
- Conduct conventional policy with the State: Leem is the privileged interlocutor and referent of the public authorities for medicines;
- Negotiate with social partners;
- Promote ethical and responsible behavior within the sector.
I have a project. How can contacting Leem help me?
- Understand and decipher the environment of the pharmaceutical sector;
- Access in-depth, quantified and well-argued studies and analyses related to the sector's major issues and current affairs;
- Benefit from the knowledge of industry experts;
- Be accompanied on individual issues.
At what stage of my project should I contact your organization?
At the very beginning of your project's conception if you are a drug company or operating in the pharmaceutical field. Otherwise, when a proof of concept in collaboration with a drug company has been established.
Does it finance projects?
No, but the Fondation du Leem, which regularly launches calls for projects to support actions promoting access to healthcare in France.
Accessible resources
- Scientific, legal and regulatory news, etc.
- Newsletters ;
- Transparency database ;
- Job exchange ;
- Data room ;
- Thematic meetings ;
- Studies and publications ;
- Educational tools (best practice guides, booklets, etc.) ;
- Hotline dedicated to members.
Practical Guide
All the questions you need to ask about Leem.
Who's the right person to talk to?
- For any questions relating to the Académie du Digital en Santé, you can write to contact@academiedudigitalensante.fr
- For any other questions relating to Leem's "digital" and "health data" activities, you can write to Esante@leem.org
Do you charge for your services?
Yes, through membership of Leem.
Can Leem support my project individually?
Leem's role is to decipher, inform on the entire drug ecosystem, and particularly on associated digital services.
What are Leem's priorities in terms of digital healthcare?
In July 2019, Leem created a "transverse expert" commission to strengthen the efficiency and transparency of its work on digital, data and new healthcare technologies. In consultation with its members, the "Digital, Data and New Technologies" Commission has defined 3 priority areas:
- Foster the development of digital culture and skills within healthcare companies, via the creation of the Academy of Digital Health;
- Build and promote a common vision and position aimed at fostering the role and place of pharmaceutical companies in digital health, which involves the drafting of a white paper "Leem's commitment to digital" and studies on the levers that can encourage the scaling up of digital health projects...;
- Ensure the integration of drug-related issues in the implementation and exploitation of health data, which translates into various works on health data, including participation in the structuring of the Health Data Hub.
58 Boulevard Gouvion-Saint-Cyr 75017 Paris